[EN] CONJUGATES OF A GLYCOPROTEIN OR A GLYCAN WITH A TOXIC PAYLOAD<br/>[FR] CONJUGUÉS D'UNE GLYCOPROTÉINE OU D'UN GLYCANE AVEC UNE CHARGE TOXIQUE
申请人:GLYKOS FINLAND OY
公开号:WO2014177771A1
公开(公告)日:2014-11-06
The invention relates to a glycoprotein-toxic pay- load molecule conjugate, a toxic payload molecule- glycan conjugate, and a pharmaceutical composi- tion.The invention further relates to a method for preparing the glycoprotein-toxic payload mole- cule conjugate, the method for modulating growth of a cell population and a method of treating tu- mour cells.
CONJUGATES OF A GLYCOPROTEIN OR A GLYCAN WITH A TOXIC PAYLOAD
申请人:GLYKOS FINLAND OY
公开号:US20160106860A1
公开(公告)日:2016-04-21
The invention relates to a glycoprotein-toxic payload molecule conjugate, a toxic payload molecule-glycan conjugate, and a pharmaceutical composition. The invention further relates to a method for preparing the glycoprotein-toxic payload molecule conjugate, the method for modulating growth of a cell population and a method of treating tumour cells.
The invention relates to novel linker-payload molecule conjugates. The invention also relates to novel cell binder-linker-payload molecule conjugates, in particular antibody conjugates of dolastatin or auristatin derivatives.
[EN] LINKER-PAYLOAD MOLECULE CONJUGATES<br/>[FR] CONJUGUÉS CONSTITUÉS DE MOLÉCULES DE CHARGE UTILE ET DE LIEURS
申请人:GLYKOS FINLAND OY
公开号:WO2014096551A1
公开(公告)日:2014-06-26
The invention relates to novel linker-payload molecule conjugates. The invention also relates to novel cell binder-linker-payload molecule conjugates, in particular antibdy conjugates of dolastatin or auristatin derivatives.
[EN] ANTIBODY DRUG CONJUGATES BINDING TO HIGH-MANNOSE N-GLYCAN<br/>[FR] CONJUGUÉS MÉDICAMENT-ANTICORPS SE LIANT À UN N-GLYCANE À HAUTE TENEUR EN MANNOSE
申请人:GLYKOS FINLAND OY
公开号:WO2015197919A1
公开(公告)日:2015-12-30
The invention relates to a binding agent comprising a payload molecule and a first binding component comprising the complementarity determining regions of an antibody, wherein said antibody is capable of binding a high-mannose N-glycan.